Spravato®

Company

Janssen Therapeutics

Use

Treatment-resistant depression

Features

Esketamine nasal spray used with oral antidepressant.

NIH Contribution

Research on treatment-resistant intranasal ketamine for depression.

Success Stories

https://www.techtransfer.nih.gov/news/julys-featured-product-first-fda-approved-prescription-nasal-spray-for-treatment-resistant

HHS Institute/Agency

NIMH

Inventor(s)

Charney, D. et al.

Year

2019

Request More Info